4//SEC Filing
ELITE PHARMACEUTICALS INC /NV/ 4
Accession 0001493152-25-012347
$ELTPCIK 0001053369operating
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 5:17 PM ET
Size
9.3 KB
Accession
0001493152-25-012347
Insider Transaction Report
Form 4
ELITE PHARMACEUTICALS INC /NV/
EVP Operations
Transactions
- Sale
Common Stock
2025-08-22$0.52/sh−500,000$262,150→ 1,800,000 total - Exercise/Conversion
Common Stock
2025-08-25$0.03/sh+2,500,000$75,000→ 4,300,000 total - Exercise/Conversion
Stock Options (right to buy)
2025-08-25−2,500,000→ 2,500,000 totalExercise: $0.03Exp: 2033-01-03→ Common Stock (2,500,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.52 to $0.56, inclusive. The reporting person undertakes to provide to Elite Phannaceuticals, any security holder of Elite Pharmaceuticals, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote(1) to this Form 4
- [F2]All of the stock options were fully vested and exercisable as of the transaction date.
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0001053369
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 5:17 PM ET
- Size
- 9.3 KB